1081 related articles for article (PubMed ID: 24140293)
1. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
2. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
Haltiwanger RS; Grove K; Philipsberg GA
J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
[TBL] [Abstract][Full Text] [Related]
3. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
Johnson B; Opimba M; Bernier J
Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
Park SY; Ryu J; Lee W
Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
[TBL] [Abstract][Full Text] [Related]
5. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
Vosseller K; Wells L; Lane MD; Hart GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
[TBL] [Abstract][Full Text] [Related]
6. Glucosamine modulates TNF-α-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells.
Chen CL; Liang CM; Chen YH; Tai MC; Lu DW; Chen JT
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2281-91. PubMed ID: 22427561
[TBL] [Abstract][Full Text] [Related]
7. The synthesis and biological evaluation of some carbocyclic analogues of PUGNAc.
Scaffidi A; Stubbs KA; Vocadlo DJ; Stick RV
Carbohydr Res; 2008 Nov; 343(16):2744-53. PubMed ID: 18804755
[TBL] [Abstract][Full Text] [Related]
8. Selective decrease of membrane-associated PKC-alpha and PKC-epsilon in response to elevated intracellular O-GlcNAc levels in transformed human glial cells.
Matthews JA; Acevedo-Duncan M; Potter RL
Biochim Biophys Acta; 2005 Apr; 1743(3):305-15. PubMed ID: 15843043
[TBL] [Abstract][Full Text] [Related]
9. Identification of differentially expressed proteins by treatment with PUGNAc in 3T3-L1 adipocytes through analysis of ATP-binding proteome.
Lee JE; Park JH; Moon PG; Baek MC
Proteomics; 2013 Oct; 13(20):2998-3012. PubMed ID: 23946262
[TBL] [Abstract][Full Text] [Related]
10. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.
Gao Y; Wells L; Comer FI; Parker GJ; Hart GW
J Biol Chem; 2001 Mar; 276(13):9838-45. PubMed ID: 11148210
[TBL] [Abstract][Full Text] [Related]
11. The protective effects of PUGNAc on cardiac function after trauma-hemorrhage are mediated via increased protein O-GlcNAc levels.
Zou L; Yang S; Hu S; Chaudry IH; Marchase RB; Chatham JC
Shock; 2007 Apr; 27(4):402-8. PubMed ID: 17414423
[TBL] [Abstract][Full Text] [Related]
12. Relationship between protein O-linked glycosylation and insulin-stimulated glucose transport in rat skeletal muscle following calorie restriction or exposure to O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate.
Arias EB; Cartee GD
Acta Physiol Scand; 2005 Mar; 183(3):281-9. PubMed ID: 15743388
[TBL] [Abstract][Full Text] [Related]
13. Dynamic nuclear and cytoplasmic glycosylation: enzymes of O-GlcNAc cycling.
Iyer SP; Hart GW
Biochemistry; 2003 Mar; 42(9):2493-9. PubMed ID: 12614143
[No Abstract] [Full Text] [Related]
14. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells.
Dauphinee SM; Ma M; Too CK
J Cell Biochem; 2005 Oct; 96(3):579-88. PubMed ID: 16052526
[TBL] [Abstract][Full Text] [Related]
15. Modulation of transcription factor function by O-GlcNAc modification.
Ozcan S; Andrali SS; Cantrell JE
Biochim Biophys Acta; 2010; 1799(5-6):353-64. PubMed ID: 20202486
[TBL] [Abstract][Full Text] [Related]
16. Cytosolic O-GlcNAc accumulation is not involved in beta-cell death in HIT-T15 or Min6.
Okuyama R; Yachi M
Biochem Biophys Res Commun; 2001 Sep; 287(2):366-71. PubMed ID: 11554736
[TBL] [Abstract][Full Text] [Related]
17. Identification of a specific inhibitor of nOGA - a caspase-3 cleaved O-GlcNAcase variant during apoptosis.
Li J; Li Z; Li T; Lin L; Zhang Y; Guo L; Xu Y; Zhao W; Wang P
Biochemistry (Mosc); 2012 Feb; 77(2):194-200. PubMed ID: 22348480
[TBL] [Abstract][Full Text] [Related]
18. Conformational flexibility of the glycosidase NagZ allows it to bind structurally diverse inhibitors to suppress β-lactam antibiotic resistance.
Vadlamani G; Stubbs KA; Désiré J; Blériot Y; Vocadlo DJ; Mark BL
Protein Sci; 2017 Jun; 26(6):1161-1170. PubMed ID: 28370529
[TBL] [Abstract][Full Text] [Related]
19. PUGNAc treatment leads to an unusual accumulation of free oligosaccharides in CHO cells.
Mehdy A; Morelle W; Rosnoblet C; Legrand D; Lefebvre T; Duvet S; Foulquier F
J Biochem; 2012 Apr; 151(4):439-46. PubMed ID: 22337894
[TBL] [Abstract][Full Text] [Related]
20. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]